Find similar products:
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 08828/0358.
Tyenne 162 mg solution for injection in pre-filled syringe
Tyenne® 162 mg
Solution for injection in pre-filled syringe
tocilizumab
Subcutaneous use
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
In addition to this leaflet, you will be given a Patient Alert Card, which contains important safety information that you need to be aware of before and during treatment with Tyenne.
1. What Tyenne is and what it is used for
2. What you need to know before you use Tyenne
3. How to use Tyenne
4. Possible side effects
5. How to store Tyenne
6. Contents of the pack and other information
Tyenne contains the active substance tocilizumab, which is a protein made from specific immune cells (monoclonal antibody), that blocks the action of a specific protein (cytokine) called interleukin-6. This protein is involved in inflammatory processes of the body, and blocking it can reduce the inflammation in your body. Tyenne is used to treat:
If either of these applies to you, tell a doctor. Do not use Tyenne.
Talk to your doctor, pharmacist or nurse before using Tyenne.
Your doctor will perform a blood test before you receive Tyenne, to determine if you have a low white blood cell count, low platelet count or high liver enzymes.
Tyenne pre-filled syringe is not recommended for use in children under 1 year of age.
Tyenne must not be given to children with sJIA (systemic juvenile idiopathic arthritis) weighing less than 10 kg.
If a child has a history of macrophage activation syndrome (activation and uncontrolled proliferation of specific blood cells), tell your doctor. Your doctor will have to decide if they can still be given Tyenne.
Tell your doctor if you are taking any other medicines, or have recently taken any. Tyenne can affect the way some medicines work, and the dose of these may require adjustment. If you are using medicines containing any of the following active substances, tell your doctor:
Due to lack of clinical experience, Tyenne is not recommended for use with other biological medicines for the treatment of RA, sJIA, pJIA or GCA.
Regarding vaccinations, please see the section on warnings above.
Tyenne is not to be used in pregnancy unless clearly necessary. Talk to your doctor if you are pregnant, may be pregnant, or intend to become pregnant.
Women of childbearing potential must use effective contraception during and up to 3 months after treatment.
Stop breast-feeding if you are to be given Tyenne, and talk to your doctor. Leave a gap of at least 3 months after your last treatment before you start breast-feeding. It is not known whether Tyenne passes into breast milk.
This medicine can cause dizziness. If you feel dizzy, do not drive or use machines.
Always use this medicine exactly as your doctor, pharmacist or nurse has told you. You should check with your doctor, pharmacist or nurse if you are not sure.
The treatment will be prescribed and started by healthcare professionals experienced in the diagnosis and treatment of RA, sJIA, pJIA or GCA.
The recommended dose for RA (rheumatoid arthritis) and GCA (giant cell arteritis) for adults is 162 mg (the content of 1 pre-filled syringe) given once a week.
The usual dose of Tyenne depends on the patient’s weight.
The usual dose of Tyenne depends on the patient’s weight.
Tyenne is given by injection under the skin (subcutaneously). At the start, your doctor or nurse may inject Tyenne. However, your doctor may decide that you may inject Tyenne yourself. In this case you will get training on how to inject Tyenne yourself. Parents and carers will get training on how to inject Tyenne for patients who cannot inject themselves, such as children.
Talk to your doctor if you have any questions about giving yourself or a child patient you look after an injection. You will find detailed “Instructions for administration” at the end of this leaflet.
Because Tyenne is given in one pre-filled syringe, it is unlikely that you will receive too much. However, if you are worried, talk to your doctor, pharmacist or nurse.
If an adult with RA or GCA or a child or adolescent with sJIA misses or forgets a dose, it is very important to use Tyenne exactly as prescribed by your doctor. Keep track of your next dose.
It is very important to use Tyenne exactly as prescribed by the doctor. Keep track of the next dose.
You should not stop using Tyenne without discussing with your doctor first.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, Tyenne can cause side effects, although not everybody gets them. Side effects could occur 3 months or more after your last dose of Tyenne.
These are common: they may affect up to 1 in 10 people
Allergic reactions during or after injection:
If you notice any of these, tell your doctor immediately.
Signs of serious infections:
Signs and symptoms of liver toxicity
These may affect up to 1 in 1 000 people
If you notice any of these, tell your doctor as soon as possible.
Very common side effects:
These may affect 1 in 10 people or more
Common side effects:
These may affect up to 1 in 10 people
Uncommon side effects:
These may affect up to 1 in 100 people
Rare side effects:
These may affect up to 1 in 1 000 people
Very rare side effects:
These may affect up to 1 in 10 000 people
Side effects in children and adolescents with sJIA or pJIA are generally similar to those in adults. Some side effects are seen more often in children and adolescents: inflamed nose and throat, headache, feeling sick (nausea) and lower white blood cell counts.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
Ireland
UK
or search for MHRA Yellow Card in the Google Play or Apple App Store
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pre-filled syringe label and carton (EXP). The expiry date refers to the last day of that month.
Store in a refrigerator (2°C - 8°C). Do not freeze.
Keep the pre-filled syringes in the outer carton in order to protect from light.
A single pre-filled syringe may be stored at temperatures up to a maximum of 25°C for a single period of up to 14 days. The pre-filled syringe must be protected from light, and discarded if not used within the 14 day period.
Do not use if the medicine is cloudy or contains particles, is any colour besides colourless to pale yellow, or any part of the pre-filled syringe appears to be damaged.
The syringe should not be shaken.
After removing the cap the injection must be started right away to prevent the medicine from drying out and blocking the needle. If the pre-filled syringe is not used right away after cap removal, you must dispose of it in a puncture resistant container and use a new pre-filled syringe.
If following insertion of the needle, you cannot depress the plunger, you must dispose of the pre-filled syringe in a puncture resistant container and use a new pre-filled syringe.
The active substance is tocilizumab
The other ingredients are L-arginine, L-histidine, L-lactic acid, sodium chloride, polysorbate 80, hydrochloric acid (E507) and/or sodium hydroxide (E524), water for injections.
Tyenne is a solution for injection. The solution is clear and colourless to pale yellow.
Tyenne is supplied as a 0.9 mL pre-filled syringe containing 162 mg tocilizumab solution for injection.
Each pack contains 1, 4 or 12 pre-filled syringes. Not all pack sizes may be marketed.
For EU:
For GB:
This leaflet was last revised in July 2023.
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu/.
Tyenne® 162 mg
Solution for injection in pre-filled syringe
tocilizumab
Subcutaneous use
Storing Tyenne pre-filled syringes
Do not freeze Tyenne.
Do not use Tyenne pre-filled syringe that has been frozen or left in direct sunlight because it could lead to illness.
Using Tyenne pre-filled syringe
Do not share your Tyenne pre-filled syringe with another person. You may give another person an infection or get an infection from them.
Do not use the pre-filled syringe if the sealed plastic tray or carton are open or damaged.
Do not use the pre-filled syringe if it has been dropped on a hard surface.
The pre-filled syringe may be broken even if you cannot see the break.
Do not remove the needle cap from the pre-filled syringe until you are ready to inject.
Do not try to reuse the pre-filled syringe because it could lead to an infection.
Travelling with Tyenne pre-filled syringe
Do not try to activate the clear needle guard before injecting.
1.1 Prepare a clean, flat surface, such as a table or counter top, in a well-lit area.
1.2 Supplies needed (Figure B):
1.3 Take the Tyenne carton out of the refrigerator and open it (Figure C).
1.4 Remove Tyenne sealed plastic tray out of the carton:
1.5 Let the pre-filled syringe in its sealed plastic tray sit at room temperature for at least 30 minutes before use to allow the medicine to reach room temperature (Figure D). Injecting cold medicine can cause your injection to feel uncomfortable and make it difficult to push the plunger in.
Do not speed up the warming process in any way, such as in a microwave, or placing the syringe in hot water, or direct sunlight.
Do not remove the needle cap while allowing your Tyenne pre-filled syringe to reach room temperature.
1.6 Prepare and check your records of previous injection sites. This will help you choose the appropriate injection site for this injection (see Step 8 “Record your injection”).
2.1 Wash your hands well with soap and water and dry them with a clean towel (Figure E).
Remove Tyenne pre-filled syringe from the sealed plastic tray
Do not pick up the pre-filled syringe by the plunger or the needle cap. Doing so could damage the pre-filled syringe or activate the clear needle guard.
3.1 Check the pre-filled syringe to make sure that:
Do not use the syringe if it shows any sign of damage. If damaged, call your doctor or pharmacist right away and throw away the syringe in your sharps disposal container (see Step 7 “Throw away your syringe”).
3.2 Check the liquid through the clear window of the syringe to make sure that:
Do not use the pre-filled syringe if the liquid is cloudy, discolored, contains particles or flakes, or shows any sign of damage. If the liquid is cloudy, discolored, contains particles or flakes, call your doctor or pharmacist right away and throw away the syringe in your sharps disposal container (see Step 7 “Throw away your syringe”).
3.3 Check the label on the pre-filled syringe to make sure that:
Do not use the pre-filled syringe if:
If the label does not have Tyenne on it or the expiration date has passed contact your doctor or pharmacist right away and throw away the pre-filled syringe in your sharps disposal container (see Step 7 “Throw away your syringe”).
4.1 Choose an injection site (Figure L):
Do not attempt to use the upper arm area by yourself. Only inject into the sites shown.
4.2 Choose a different injection site (at least 3 cm from the last area you injected) for each new injection to reduce redness, irritation or other skin problems.
Do not inject into an area that is sore (tender), bruised, red, hard, scarred or where you have stretch marks, moles or tattoos.
If you have psoriasis, do not inject into any lesions or red, thick, raised or scaly patches.
5.1 Wipe the skin of your injection site with an alcohol swab in a circular motion to clean it (Figure N). Let the skin dry before injecting.
Do not blow or touch the injection site after cleaning.
6.1 Remove the needle cap
Do not hold the plunger while you remove the needle cap.
Note: after removing the cap use the pre-filled syringe right away to prevent the medicine from drying out and blocking the needle.
Do not try to recap the needle at any time, even at the end of the injection.
If you cannot remove the needle cap, you should ask a caregiver for help or contact your doctor.
You may see drops of liquid at the needle tip. This is normal and will not affect your dose.
Do not touch the needle or let it touch any surface after removing the needle cap, because this might cause an accidental needle stick.
6.2 Pinch the skin
6.3 Insert the needle
Hold the pre-filled syringe like a pencil.
It is important to use the correct angle to make sure the medicine is delivered under the skin (into fatty tissue), or the injection could be painful, and the medicine may not work.
6.4 Inject
Do not pull the needle out of the skin when the plunger is pushed all the way down.
6.5 Finish Injection
Important: Call your doctor right away if:
Injecting an incorrect amount of medicine could affect your treatment.
Do not reuse a syringe even if all of the medicine was not injected.
Do not try to recap the needle as it could lead to needle stick injury.
6.6 After Injection
If there is blood or liquid on the injection site, gently press a cotton ball or gauze on the skin (Figure U). You may use an adhesive bandage if needed.
Do not rub the injection site.
7.1 Put your used syringe in a sharps disposal container right away after use (Figure V).
If you do not have a sharps disposal container, you may use a household container that is:
When your sharps disposal container is almost full, you will need to follow your local guidelines to dispose of your sharps disposal container. Do not throw away (dispose of) used syringes in your household trash.
Do not dispose of your used sharps disposal container in your household trash unless your local guidelines permit this.
Do not recycle your used sharps disposal container.
Keep Tyenne pre-filled syringes and disposal container out of the reach and sight of children.
8.1 To help you remember when and where to give your next injection, write the date, time, and specific part of your body where you injected yourself. (Figure W).
It may also be helpful to write any questions or concerns about the injection, so you can ask your doctor.
If you have questions or concerns about your Tyenne pre-filled syringe, please contact your doctor familiar with Tyenne.
Important information